ResMed Global General Counsel Earns 3,230 Performance Shares
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filed for RESMED INC ($RMD) Insider: Rider Michael J (Global General Counsel) Transaction: Acquisition (Award) of 3,230 shares at $0.00 Total Value: $0 Shares Held After: 12,718 Date of Transaction: 2026-08-14 Filing Date: 2026-10-01
Comprehensive Analysis
Executive Summary
On October 1, 2026, ResMed Inc. ($RMD) filed a Form 4 disclosing that Global General Counsel Michael J. Rider acquired 3,230 shares of ResMed Common Stock on August 14, 2026.
Transaction Details
- Security: ResMed Common Stock
- Transaction Code: A (Award/Grant)
- Shares Acquired: 3,230
- Price per Share: $0.00
- Total Transaction Value: $0.00
- Post-Transaction Direct Ownership: 12,718 shares
Context & Footnote Analysis
The transaction reflects performance-based restricted stock units (PRSUs) initially granted on November 20, 2025. On August 14, 2026, the compensation and leadership development committee certified that the applicable performance metrics were met, confirming the earned shares. The earned RSUs vest in three equal annual installments on each anniversary of the original grant date.
Trading Significance
This transaction carries Low trading significance as it represents the routine vesting/certification of an equity incentive award at zero cost rather than open-market buying or selling.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.